Skip to main content
. Author manuscript; available in PMC: 2007 Nov 15.
Published in final edited form as: J Nucl Med. 2002 May;43(5):678–692.

TABLE 2.

Regional DV Values After Injection of (+)-11C-McN5652 or 11C-DASB

Radioligand* Pons MB Hypo Thalamus Put Cd FC PC TC CC OC Cereb
11C-McN5652
 Control 29.4 ± 1.4 40.2 ± 2.7 46.1 ± 2.6 33.4 ± 1.2 23.6 ± 1.3 22.0 ± 1.4 12.9 ± 0.3 14.4 ± 0.5 15.5 ± 0.2 14.9 ± 0.5 14.3 ± 0.2 13.7 ± 0.3
 MDMA 17.4 ± 1.2 22.5 ± 2.5 21.2 ± 2.4 14.4 ± 0.6 11.2 ± 0.7 11.8 ± 0.9  8.2 ± 0.6  8.6 ± 0.4 10.0 ± 0.8  9.2 ± 0.3  8.4 ± 0.4  8.7 ± 0.4
 Paroxetine 14.8 ± 3.2 15.3 ± 2.7 15.3 ± 2.8 16.9 ± 3.3 18.3 ± 3.6 16.7 ± 3.1 13.2 ± 2.2 14.3 ± 2.4 15.1 ± 1.8 13.5 ± 2.5 14.3 ± 2.4 13.0 ± 2.3
11C-DASB
 Control 46.2 ± 11.1 71.3 ± 14.8 79.8 ± 11.2 45.5 ± 4.5 22.2 ± 3.3 27.5 ± 2.7 9.8 ± 1.3 9.2 ± 1.0 11.6 ± 1.4 11.5 ± 1.4 9.0 ± 0.9 9.2 ± 0.7
 MDMA 26.5 ± 2.7 31.3 ± 1.4 31.3 ± 5.6 15.9 ± 1  8.9 ± 0.9 11.5 ± 0.9 6.1 ± 0.2 5.9 ± 0.3  7.2 ± 0.7  6.9 ± 0.3 6.0 ± 0.3 6.3 ± 0.4
 Paroxetine  7.7 ± 0.8  7.9 ± 0.8  8 ± 0.8  8.3 ± 0.6  7.9 ± 0.6  7.6 ± 0.7 6.9 ± 0.7 7.3 ± 0.5  7.4 ± 0.6  7.1 ± 0.6 7.3 ± 0.5 6.9 ± 0.7
*

Each radioligand was tested 3 times in control baboon or different baboon lesioned previously with serotonergic neurotoxin MDMA.

Designates significant difference from control (ANOVA without correction for multiple comparisons).

Designates significant difference from control (ANOVA with correction for multiple comparisons).

Designates significant difference from MDMA (ANOVA without correction for multiple comparisons).

MB = midbrain; Hypo = hypothalamus; Put = putamen; Cd = caudate; FC = frontal cortex; PC = parietal cortex; TC = temporal cortex; CC = cingulate cortex; OC = occipital cortex; Cereb = cerebellum.

Values represent mean ± SD (n = 3).

HHS Vulnerability Disclosure